# Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

> **NCT03479229** · NA · COMPLETED · sponsor: **Viveve Inc.** · enrollment: 250 (actual)

## Conditions studied

- Female Sexual Dysfunction

## Interventions

- **DEVICE:** Geneveve Treatment
- **DEVICE:** Sham Treatment

## Key facts

- **NCT ID:** NCT03479229
- **Lead sponsor:** Viveve Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479229, "Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03479229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*